Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasm Metastasis 2Lung Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Precancerous Conditions 1Pleural Effusion, Malignant 1Osteoporosis 1Neoplasms 1Lymphatic Metastasis 1Gliosarcoma 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Spectrum Analysis × Clear all
NCT00899288 2012-07-27

Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98

ETOP IBCSG Partners Foundation

Phase 3 Terminated
60 enrolled
Breast

Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡